ADHD as a Risk Factor for Postpartum Depression and Anxiety
ADHD is an important risk factor for both depression and anxiety disorders in the postpartum period and should be considered in the post-pregnancy maternal care.
Zuranolone: A novel postpartum depression treatment, with lingering questions
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on zuranolone for postpartum depression with Ob.Gyn News on August 15, 2023.
Using Predictive Modeling to Examine IV Ketamine and Esketamine for the Prevention of Postpartum Depression
Intravenous ketamine or esketamine given at the time of cesarean delivery reduced risk for postpartum depression; predictive models are needed to determine which women are most likely to benefit from this intervention.
FDA Approves Zuranolone for the Treatment of Postpartum Depression
The FDA approves zuranolone, a new option for the treatment of PPD, a rapidly acting antidepressant with a good safety profile.
More Data on Zuranolone for Postpartum Depression: When Will It Hit the Market?
In women with severe postpartum depression, zuranolone was associated with improvements in depression beginning at day 3. FDA to make a decision next week.
Post-Marketing Safety Data for Brexanolone (Zulresso)
In this postmarketing surveillance data analysis, excessive sedation and loss of consciousness when receiving brexanolone occurred at lower rates than previously reported in clinical trials.
Coach-Supported Web-Based Intervention for Mild to Moderate Postpartum Depression
This preliminary study suggests that web-based interventions with coaching are feasible, acceptable, and potentially effective treatment options for women with mild to moderate postpartum depression and/or anxiety.
Zuranolone Improves Anxiety Symptoms and Insomnia in Women with Postpartum Depression
In women with postpartum depression, zuranolone was associated with concurrent improvements in depression, anxiety symptoms, and insomnia beginning at day 3.
PPD Screening and Treatment: Is There Room for Improvement? A New Study at Mass General Brigham
Announcing a new CWMH study on postpartum depression screening and treatment outcomes at Mass General Brigham.
Risk Factors for Postpartum Depression: Family History of Psychiatric Illness
Family history of psychiatric illness was associated a twofold increased risk for postpartum depression.